SYNCOM FORMULATIONS (INDIA)
Back to Cashflow Statement
|
SYNCOM FORMULATIONS (INDIA) Last 5 Year Cash Flow from Investing Activities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2017 | Mar2016 | |
---|---|---|---|---|---|
Cash Flow from Investing Activities | ₹83 Cr | ₹-45 Cr | ₹-27 Cr | ₹-18 Cr | ₹-23 Cr |
What is the latest Cash Flow from Investing Activities ratio of SYNCOM FORMULATIONS (INDIA) ?
Year | Cash Flow from Investing Activities |
---|---|
Mar2024 | ₹83 Cr |
Mar2023 | ₹-45 Cr |
Mar2022 | ₹-27 Cr |
Mar2017 | ₹-18 Cr |
Mar2016 | ₹-23 Cr |
How is Cash Flow from Investing Activities of SYNCOM FORMULATIONS (INDIA) Trending?
Years | Cash Flow from Investing Activities | % Change | |
---|---|---|---|
Mar2024 | ₹83 Cr | Positive | |
Mar2023 | ₹-45 Cr | Negative | |
Mar2022 | ₹-27 Cr | Negative | |
Mar2017 | ₹-18 Cr | Negative | |
Mar2016 | ₹-23 Cr | - |
Compare Cash Flow from Investing Activities of peers of SYNCOM FORMULATIONS (INDIA)
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
SYNCOM FORMULATIONS (INDIA) | ₹2,051.1 Cr | -7.6% | 2.9% | 87.4% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹435,179.0 Cr | 0.4% | 0.8% | 45.4% | Stock Analytics | |
DIVIS LABORATORIES | ₹155,995.0 Cr | -1.4% | 1.2% | 62% | Stock Analytics | |
CIPLA | ₹116,890.0 Cr | -1.5% | -5.1% | 20.3% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹103,993.0 Cr | -0.7% | -1.3% | 13.8% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹98,444.9 Cr | -0.5% | 3% | 54.1% | Stock Analytics |
SYNCOM FORMULATIONS (INDIA) Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
SYNCOM FORMULATIONS (INDIA) | -7.6% |
2.9% |
87.4% |
SENSEX | 0.5% |
3.3% |
17.6% |
You may also like the below Video Courses